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Abstract 
The capability of 3D printing technologies for direct production of complex 3D structures in 
a single step has recently attracted an ever increasing interest within the field of 
microfluidics. Recently, ultrafast lasers have also allowed developing new methods for 
production of internal microfluidic channels within the bulk of glass and polymer materials 
by direct internal 3D laser writing. This review critically summarizes the latest advances in 
the production of microfluidic 3D structures by using 3D printing technologies and direct 
internal 3D laser writing fabrication methods. Current applications of these rapid prototyped 
microfluidic platforms in biology will be also discussed. These include imaging of cells and 
living organisms, electrochemical detection of viruses and neurotransmitters, and studies in 
drug transport and induced-release of adenosine triphosphate from erythrocytes. 
I. Introduction 
During the past three decades, microfluidic systems have evolved from relatively simple 
single-function devices to multiple-function analytical systems
1
 used for a wide range of 
biological applications in clinical and forensic analysis,
2
 proteomics and metabolomics,
1
 
immunoassays,
3
 cell analysis,
1
 point-of-care (POC) diagnostics,
1
 drug discovery,
4
 genetic 
analysis,
5
 and organs-on-chip.
6–9
 These micro scale systems have a number of advantages 
over traditional macro scale methods used in biological and biomedical research, including 
the capability of (i) streamlining complex assay protocols, (ii) providing investigators with 
accurate manipulation of the cell microenvironment, and (iii) reducing the sample and 
reagent volume maximising the information obtained from precious samples and reducing 
costs. However, most of the publications in the field of microfluidics are still appearing in 
engineering journals (85% in 2010) compared to biology and medical journals.
10
 This 
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indicates that there is still a lot of scope for further bio-focused research in microfluidics as 
well as for the emergence of new bio application domains in the coming years. 
 
In fact, though microfluidics is widely considered to be a key component in both 
development of laboratory-based, high-throughput analytical methods and POC diagnostics, a 
“killer application” for microfluidics is still anticipated.11–13 Such an application is one that 
will generate large revenue in a relatively short period of time and will strongly promote the 
microfluidic industry as a whole. In a recent series of articles by Becker it is suggested that 
the diagnostic market is one such area where microfluidics will find its niche.
12,13
 However, 
before this is realised a significant amount of work still needs to be carried out in the area of 
design, manufacture, and integration of microfluidic components (e.g. valves, micropumps, 
and separation columns) within a single microfluidic platform.
14,15
 Thus, recent advances in 
rapid prototyping (RP) techniques, such as the availability of 3D RP equipment with much 
higher resolution, have the ability to propel the field of microfluidics forward towards finding 
such a “killer application” by easing the fabrication of complex designs as well as speeding 
up the fabrication process allowing for mass production. 
 
3D printing
16
 and direct internal 3D laser writing
17
 methods allow for direct fabrication of 3D 
microstructures in one single step. In comparison, standard replication methods for 
fabrication of microfluidic devices such as injection moulding, hot embossing and casting 
(i.e. soft lithography
18
) can be termed multistep manufacturing methods as they require the 
creation of a replication master before casting or moulding of the final device. These 
replication methods, while particularly useful for industrial scale manufacture in the case of 
injection moulding, are often expensive and time-consuming on a smaller scale owing to the 
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need for fabrication of the replication master. Alternatively, direct microfabrication methods 
such as computer-numerical-control (CNC) milling and 2D laser surface ablation allow for 
direct fabrication of microchannels on a variety of substrates, including glass and polymers. 
However, all these standard microfabrication methods typically lead to the production of 
open channels on the surface of a substrate, which then need to be sealed by an additional 
layer creating an enclosed microfluidic channel. Thus, standard microfabrication methods 
employed in microfluidics will generally involve a multistep procedure as compared to 3D 
printing and direct internal 3D laser writing methods. In this paper, these direct 3D 
fabrication methods are presented and their capabilities for fabrication of microfluidic 
devices for biological applications are reviewed. 
II. 3D printing fabrication methods 
The term 3D printing covers a wide range of techniques, some of which are already well 
established and widely used in industry. That is the case of stereolithography (SL), also 
sometimes referred to as micro-stereolithography (µSL), which is one of the most important 
rapid prototyping processes in industry today.
19
 SL allows for the automated production of 
complex 3D shapes in polymeric materials at low to medium volume throughputs.
20
 SL 
presents an inherent advantage over other lithographic methods (i.e. photolithography and 
soft lithography) in that no alignment or bonding is necessary to produce 3D structures. SL, 
developed by Hull in 1986,
21
 involves curing a photocurable liquid polymer layer by layer 
using a UV light to build up a solid 3D object. 
A list of popular commercially available high resolution SL systems and their corresponding 
attributes is given in Table I. These systems range from the Form 1+ at the lower end of the 
price scale to DigitalWax and EnvisionTEC systems at the higher end. This large discrepancy 
in price could be attributed to three main factors: resolution, build area, and build speed. 
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Table I. Commercially available SL systems, quoted specifications, and approximate prices. 
Company Model 
Resolution (μm) Available Resins Price 
XY Z Transparent Biocompatible $ 
Formlabs Form 1+ 300 25 Y N 1,088 
MiiCraft MiiCraft 56 50 Y N 2,299 
Smart3D 
MiiCraft 
HR 
Not 
stated 
25 Y N 6,674 
Asiga 
Freeform 
PRO 
50 - 75 25 Y 
Y 
(coming soon) 
24,990 
 
Freeform 
Pico 
27 - 39 25 Y 
Y 
(coming soon) 
6,990 – 
8,990 
3D Systems Projet 1200 56 30 N N 4,900 
Solidator Solidator 270 30 N N 4,950 
FSL3D 
Pegasus 
Touch 
80 25 Y N 2,000 
Old World 
Laboratories 
OWL Nano 
Not 
stated 
0.1 Y N 
2,000-
5,000 
LightForge LightForge 150 25 Y N 
2,000-
5,000 
B9 Creator v1.2 50 6.35 N N 2,400 
MakeX M-One 140 20 N N 2,000 
mUVe mUVe 1 3D 100 
Not 
Stated 
N N 
599 – 
1,699 
Kudo 3D Titan 1 HD 37 1 N N 2,000 
DigitalWax Systems 
Dental 
range 
Not 
stated 
10 Y Y 
20,000-
125,000 
EnvisionTEC Perfactory 3 16 15 Y Y 100,000 
 
Curing time and resolution are defined by these parameters as well as the chosen material and 
curing method used. A variety of curing methods have been developed for use within 
commercially available SL instruments, these include laser raster scanning, laser vector 
scanning, and digital light processing (DLP) methods. In the first SL systems commercially 
introduced by 3D Systems in 1988, a low-power, highly focused UV laser was raster scanned 
according to the area to be cured. The introduction of galvanometer-based vector scanning 
regimes for the laser allowed for faster curing of each 2D layer and reduced production times. 
Projection systems have recently been introduced which allow for a complete 2D layer to be 
cured in one step. These systems employ a data projector type method of photon exposure 
often termed Digital Mirror Display (DMD).
19
 Choice of curing method can be seen to 
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depend on the specific application with vector scanning typically providing a larger build 
volume (e.g. Form 1+) compared to DLP methods which provide increased productivity (e.g. 
EnvisionTEC Perfactory 3). Most commercial systems sold today offer the ability to adjust 
the resolution to speed up productivity (lower resolution resulting in faster build speeds), 
while in some cases the lens can be changed to improve resolution further, sacrificing build 
area as a result (e.g. EnvisionTEC’s Perfactory 3 Mini Multi Lens). Figure 1 shows a 
schematic representation of these two different curing approaches, i.e. direct laser writing 
(Figure 1(a)) and DMD-based writing (Figure 1(b)).
22
 In addition, two different 
configurations are also possible depending on the orientation of the light source: the bath 
configuration (Figure 1(a)) and the layer configuration (Figure 1(b)). In the bath 
configuration the part is built from the bottom up, with the z-stage moving down into the 
resin vat after each layer has been cured to start building the next layer. The layer 
configuration uses a light source situated beneath the z-stage which cures the part through an 
optically transparent window beneath the resin vat. After each layer has been cured, the z-
stage moves upwards producing a part that is “upside down” when finished. Of these two 
configurations, the layer configuration is the most popular as the part height is not restricted 
by the size of the vat, there is less resin waste, and the layer thickness can be more readily 
controlled by the  z-stage positioning as opposed to controlling the laser depth of focus.
22
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FIG. 1. (a) Schematic of a SL bath configuration with direct laser writing and (b) a SL layer 
configuration with DMD-based writing. Reprinted with permission from Gross et al., Anal. Chem. 
86(7), 3240 (2014). Copyright 2014 American Chemical Society 
 
Folch et al. recently investigated the capabilities of SL methods for fabrication of 
microfluidic systems 
20
. They found that the main limiting factors were the effective drainage 
of the uncured liquid resin, optical clarity, and z-height resolution. Current research and 
development into photocurable and SL systems aims to overcome these limitations focusing 
toward the implementation of new advanced resins and improvement in the xy- and z- system 
resolutions. Table I presents an overview of a broad range of currently available SL systems, 
and their capabilities and prices as provided by the manufacturers. New resins exhibiting 
improved optical transparency and biocompatibility are also continuously being introduced to 
the market, which no doubt will favour further applications of 3D printing in microfluidic-
based biological assays/platforms with optical detection/imaging. For example, biostable 
resins based on polyester/polyether oligomers with acrylate or methacrylate functions, as well 
(a) (b) 
8 
 
as biodegradable composites of methacrylate-functionalised polyesters have been developed 
in recent years by DSM.
23
 These biocompatible resins have been used in SL equipment to 
produce implants meeting Intracutaneous Test standard ISO 10993-10. Another commonly 
used material is the Eshell supplied by EnvisionTEC which is classified as Class-IIa 
biocompatible. Improved biocompatibility of SL produced components could be also 
achieved via surface treatments (e.g. plasma or laser irradiation) to improve wettability or 
surface functionalisation with –OH or NH2 groups to allow biomolecule attachment.
24
 
However, for the most part, current SL resins are limited to non-biocompatible, translucent 
and opaque materials (commonly used in jewellery and structural modelling), with a limited 
range of suppliers offering a biocompatible and transparent resin option (see Table 1). In the 
case of the Asiga SL 3D printer, it is suggested by the supplier that the printed resin requires 
the application of a lacquer in a post-processing step to make it transparent. Such methods for 
achieving transparency may be difficult to apply within long narrow internal microstructures. 
Other resin properties to consider when fabricating microfluidic platforms by SL are 
permeability to gases, degree of hydrophobicity, and chemical stability in the presence of 
solvents. 
Other 3D printing methods of note are two-photon polymerisation (TPP), fused deposition 
modelling (FDM), and 3D inkjet printing.
19,22
 TPP is based on the polymerisation of a 
photocurable resin via two-photon absorption upon illumination with a femtosecond pulsed 
near-infrared laser. Compared to conventional SL, the TPP process is not hindered by the 
diffraction limit of the light source leading to much better structural resolution.
25
 Thus, 
resolutions in the order of 100 nm are feasible for TPP instruments (e.g. Nanoscribe GmbH 
systems). Honegger et al. studied different photoresists, including SU- 8, AZ1512-HS, 
polyethylene glycol (PEG), Photomer 3015, and 4-hydroxybutyl acrylate (4-HBA), for 
production of 3D structures within microfluidic channels by TPP.
26
 Results showed that PEG 
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and 4-HBA were suitable materials for production of arm structures within channels with 
submicrometer resolution.  
FDM is based on the extrusion of melted bulk material through a heated nozzle.
27
 As with the 
other 3D printing technologies, each 2D layer is traced out with subsequent layers being 
added to build up the required 3D design. Common materials used in the FDM process 
include acrylonitrile butadiene styrene (ABS), polylactic acid (PLA), and nylon. FDM 
printers can write in many colours/materials without the need for changing the filament 
between colours/materials by usage of multiple extrusion nozzles. Due to the nature of the 
printing process, the resolution achievable is limited by the xy-plotter (two stepper motors), 
the z-stepper motor, the thickness of the filament, and the extrusion nozzle diameter. FDM 
printers are widely available from companies such as RepRap, Ultimaker, MakerBot, and 3D 
Systems. Finally, 3D inkjet printing involves applying droplets of bonding resin according to 
a prescribed 2D design onto powder to bond each 2D layer. The 2D layer of bound and 
unbound powder provides support for the subsequent layer. In an alternate 3D inkjet printing 
process, a low viscosity photocurable resin is printed alongside a support material such as 
wax onto the build platform. The wax support material acts as a mould, constraining the 
liquid resin until it is hardened during the curing stage. As with other 3D printing methods, 
this process is repeated, layer by layer, until the part is finished. A post-processing step is 
then required to remove the unbound powder or wax support material. 
III. Direct internal 3D laser writing fabrication methods 
Direct internal 3D laser writing methods have been recently employed for fabrication of 
channels and other micro features (e.g. optical components) in microfluidic devices. These 
methods consist in the internal processing of in-bulk materials by laser ablation using 
ultrashort-pulsed lasers with low pulse energy.
17
 These ultrafast lasers, having pulse widths in 
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the pico- to femtosecond range, can produce high quality microstructures within glass and 
polymer materials owing to a significant reduction in the heat-affected zone (HAZ) 
surrounding the ablation focal position with decreased pulse width. Femtosecond lasers (e.g. 
800 nm Ti:sapphire), in particular, can modify materials at wavelengths for which they are 
normally transparent. This occurs by depositing energy through high-order non-linear 
absorption processes inducing optical breakdown, which makes these lasers very useful tools 
for micromachining.
28
 Femtosecond lasers also offer the possibility to produce sub-
wavelength features as these non-linear absorption processes are not limited by optical 
diffraction.
29
 A major disadvantage of these ultrafast laser systems to date has been their cost, 
with femtosecond lasers typically being three to six times more expensive than standard 
nanosecond CO2, excimer or Nd:YAG systems of similar power.  
In 1996, Davis et al. showed that it was possible to write 3D structures for fabrication of  
optical waveguides in different bulk glasses, including silica and soda-lime, via multiphoton 
interactions with femtosecond laser radiation.
30
 A procedure for fabrication of 3D 
interconnected channels as narrow as 10 m inside silica was then presented in 2001.31 It 
consisted in optical damaging of bulk silica by a 795 nm femtosecond laser, followed by 
selective etching of the written structures with hydrofluoric acid (HF) solutions.  
Photosensitive glasses such as Foturan haven been also employed for production of 3D U-
shaped microchannels following infrared femtosecond exposure.
32
 Femtosecond irradiation 
induces a local phase change in this phosensitive glass, from amorphous to crystalline. This 
process was then completed by heating and subsequent etching of the crystalline areas with 
10% HF solution. Recently, internal processing of polymethyl methacrylate (PMMA), 
polydimethylsiloxane (PDMS), polystyrene (PS), and polyvinyl alcohol (PVA) polymers has 
also been investigated.
33
 A 800 nm Ti:sapphire laser with a maximum pulse energy of 1 mJ 
was used in this work. 
11 
 
IV. Applications in biology 
Microfluidic systems are very valuable tools for fundamental studies of complex biological 
systems since they provide precise control of small volumes of fluids over very short 
distances. Flow cytometry analysis,
34
 cell-based assays (such as cytotoxicity
35
 or induced 
cellular stress assays
36
), sorting, manipulation and imaging of single-cells,
37
 and cell/tissue 
engineering,
38,39
 are just some of the current applications of microfluidics in biology. 
Microfluidics also offer the means to create and maintain environments that closely resemble 
those encountered in vivo.
40,41
 This is essential in ensuring that the experimental results are 
not biased with artefacts caused by, for example, early triggered apoptosis and, therefore, 
creating the right environment has important implications in cell analysis. Moreover, current 
microfabrication techniques allow the production of large arrays of microwells that can 
entrap single/multiple cells to perform molecular analysis,
42
 or study cell response to 
chemical and physical stimuli following exposure to different environments;
43
 the major 
advantage of this approach being the ability to perform parallel screening of a large number 
of cells.  
In addition, one of the main advantages of 3D printing over more conventional techniques 
typically employed for production of biomicrofluidic devices is the simplification of the 
process which does not require the fabrication of a replication master nor extensive 
labour.
19,20,22,44
 A 3D microvascular network enabling chaotic mixing was one of the earliest 
microfluidic devices produced by 3D printing more than 10 yr ago.
45
  The microfluidic mixer 
integrating cylindrical channels with diameters between 10 μm and 300 μm was fabricated by 
direct-write assembly of a fugitive organic ink. Sixteen-layer scaffolds were first produced by 
robotic deposition of a paraffin-based organic ink, followed by infiltration with an epoxy 
resin, and subsequent curing of the resin at 22 °C and ink removal at 60 °C. A photocurable 
resin was then infiltrated in the resulting microchannels and polymerised through a photo-
12 
 
mask for production of the final interconnected network. The efficiency of the 3D mixer was 
then tested by mixing two fluorescent dyes (red and green) as a function of varying Reynolds 
numbers (Re). Alternatively, direct printing of fugitive ink filaments within a photocurable 
gel reservoir recently allowed the fabrication of a 3D microvascular network for potential 
applications in 3D cell culture, tissue engineering, and drug delivery. Subsequent 
photopolymerisation of the gel (Pluronic F127 diacrylate) and removal of the fugitive ink led 
to the generation of the microvascular network within the hydrogel matrix.
46
 Inkjet printing 
has also been used for generation of 3D hydrogel scaffolds with embedded microchannels for 
adequate supply of nutrients and oxygen to cells in tissue engineering applications.
47
 An in-
house 3D printer capable of dispensing a chemically crosslinkable collagen hydrogel 
precursor, a heated gelatin solution (used as the sacrificial element for channel fabrication) 
and cell suspensions, allowed the generation of a 3D collagen scaffold with microfluidic 
channels capable of performing adequate perfusion of cells printed inside the scaffold.
47
 
In comparison to the above multi-step 3D printing methods, a one-step procedure was 
recently applied to the fabrication of optically transparent microfluidic devices using 
stereolithography.
20,44
 These optically transparent chips were successfully employed in 
imaging of Chinese hamster ovary (CHO) cells previously seeded within the microchannels.
20
 
Albeit a certain degree of autofluorescence was exhibited by the biocompatible resin 
employed in the chip fabrication, discrete cells were clearly observed under fluorescence as 
well as phase-contrast modes. The capability of stereolithography for direct integration of 
standard connectors to the macro-world within the final device was also demonstrated (e.g. 
female Luer connectors
20
 and 10-32 threads
44
). Breadmore et al. showed that it was possible 
to produce a 40 mm × 25 mm × 17 mm micromixer chip (including connectors) in less than 
an hour using a rather cheap 3D printer (approx.  $2,300) and incurring a material 
expenditure of only $2 (Figure 2).
44
 Gradient generators, droplet extractors and 
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isotachophoresis chips were also successfully generated with the same 3D printer confirming 
the feasibility of this approach for cost-effective, rapid prototyping of microfluidic devices, 
which could open the door to many future low-cost analytical applications.  
 
FIG. 2. Optically transparent microfluidic mixer chip integrating 10-32 threads. Reprinted with 
permission from Shallan et al., Anal. Chem. 86(6), 3124 (2014). Copyright 2014 American Chemical 
Society 
 
Integration of commercially available polycarbonate membrane inserts into a reusable 
microfluidic chip containing eight parallel channels was also demonstrated recently (Figure 
3).
48
 The chip, also integrated with standard threaded connectors, was manufactured with a 
3D printer by inkjet deposition of a biocompatible photocurable resin within approximately 4 
h. This chip was successfully employed in studying the transport of drugs (levofloxacin and 
linezolid) across a polycarbonate membrane in view of its future applications in 
pharmacokinetic profiling of cultured cells. Cell viability studies were also performed with 
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this platform via exposure of bovine pulmonary artery endothelial cells to a detergent 
(saponin) which was pumped into the channels inducing cell death. 
 
 
FIG. 3. Microfluidic chip integrating membrane inserts. Reprinted with permission from Anderson et 
al., Anal. Chem. 85(12), 5622 (2013). Copyright 2013 American Chemical Society 
Stereolithography was previously implemented for production of a two-electrode 
electrochemical flow cell with channel dimensions of 3.5 mm × 3 mm × 192/250 m.49 
Inkjet-based 3D printing technology has also been used for the fabrication of transparent 
microfluidic devices integrating interchangeable electrodes of different materials (glassy 
carbon, platinum, gold, and silver) and sizes (from 250 m to 2 mm diameter) for 
electrochemical detection.
50
 The resulting two-electrode microfluidic cells presented a 
straight channel and threaded receiving ports for integration of the electrodes as well as the 
standard connectors to the syringe pump (see Figure 4). The removable working and pseudo-
reference electrodes were prepared by insertion into PEEK fitting nuts in a serial 
configuration. This approach prevented the need for careful alignment of the electrodes with 
the microchannel each time the electrodes were interchanged. These microfluidic devices 
were successfully employed in the detection of dopamine (neurotransmitter) and nitric oxide, 
Upon insertion of themembrane i ert, buffer wasadded to the
insert and the standard solutions were pumped through the
channels for an hour at 1 μL/min. After an hour, liquid was
sampled from the insert and added to a vial containing a
solution of acetonitrile and the internal standard, ciprofloxacin.
The samples were then analyzed using LC/MS/MS to
monitor the diffusion of linezolid and levofloxacin from the
channel, across the porous membrane. After an hour of flow,
the 1.1 and 2 μM samples had between 18.4%and 20.5%drug
transport across the polycarbonate membrane (Figure 2).
Moreover, results yielded reproducible drug transport concen-
trations between runs furthering the reusability of the device.
Though it wasnot monitored in this instance, results from our
lab indicate that drug transport can occur from the insert into
the channel; of course, this transport is dependent upon the
concentrations of thedrug in thewell and in thechannel. If the
concentration ishigher in the channel, drugmoves to thewell;
if higher in thewell (e.g., if agradient isperformed that lowers
the concentration in the channel), then the drug transport is
back to the channel. Importantly, every molecule that we have
tested to date has similar transport properties, with some
differences occurring due to size of the molecule or its
hydrophobicity.
In other polymer-based devices, reusability is not an option
due to issues with maintaining seals. Contamination is also a
concern due to challenges in cleaning devices or absorption of
materials into the polymer base.20The use of anew device for
each experiment can lead to high variability between runs. Also,
the incorporation of a membrane into the polymer-based
device, typically reversibly sealed between two pieces, can be
easily compromised due to the flexibility of the support
material. Cleaning and extended usecan also weaken the fragile
membrane. Many of these problems are minimized with the
printed devices with well inserts.
Cell Viability Assessment. Commercially available cell
culture inserts were used to integrate the 3D printed device
with cultured cells. In this design, the insert clicks into place
above the channel and themembrane would contain a layer of
cultured cells as shown in Figure 3A. Furthermore, the ECs
were stained with Hoechst 33342 dye (ex. 350 nm, em. 460
nm), a simple nucleic acid stain to confirm the presence of a
confluent layer of cells on top of themembrane. The image in
Figure 3A wasobtained using afluorescencemicroscopewith a
DAPI filter, and the stained cells are visualized on top of the
membrane.
In order to determine whether this 3D printed device could
beused to study cellular status, aviability study wasperformed
using awell-known cell detergent and an EC line that is easily
cultured onto membrane inserts. Either HBSS or saponin (a
detergent used to compromise cell membranes) was flowed
through the channel under the membrane that contained
cultured ECs. It was expected that saponin would diffuse
through the polycarbonate membrane and come into contact
with theECs. Asshown in Figure3B, theECsthat were treated
with saponin had a 4-fold increase in fluorescence intensity in
comparison to the cells treated with HBSS. The Sytox Green
doesnot stain live cells, so the increased fluorescence indicates
a higher population of dead cells. The images from the
fluorescence microscope (Figure 3C) confirm this fact, as the
imageof thesaponin treated ECsshowmore fluorescence than
the image of ECs treated with HBSSalone.
The aforementioned strains on conventional fluidic mem-
branes lend virtue to the cell culture insert as it has a rugged
base, which supports themembraneand can beeasily discarded
after use. The rigidity of the 3D device when used
simultaneously with the disposable cell inserts offers a
supportive platform for a reusable fluidic device. Of course,
many of these same features are available when using static 96-
well plate systems. However, in a static system, the user is
limited to adding a fixed amount of a drug candidate to cells
cultured in awell on amicrotiter plate and allowing that fixed
amount of drug to interact with the cells for a predetermined
amount of time before removing the drug from the cells in
preparation for further dosing. Theadvantageof the3D printed
device described here is that each well/ insert can be addressed
by a fluidic stream. In this construct, the system now has the
potential to function asadynamic in vitro system; for example,
the cells could be subjected to a drug candidate at a desirable
concentration. However, by using gradient pumping schemes,
Figure 1. 3D printed device design. The final 3D printed device, top
image, contains adapters for syringe-based pumps, channels,
membra insertion port, and outlets. The side view schematic of
the device showshow the inlet addresses the channel and allows fluid
to flow under themembrane Themembrane ispart of commerci lly
available membrane insert that is manually inserted into the port on
top of the device. Finally, there is an outlet to allow fluid to leave the
device.
Figure 2. Drug transport across amembrane. Standards of the drugs
linezolid (N = 4) and levofloxacin (N = 5) were flowed through the
channels of the device; samples were collected above the membrane
and analyzed viaLC/MS/MS. Asconcentration of thedrug increased,
so did transport across the membrane with each concentration being
statistically different from the previous (p value <0.001). Drug
transport across the membrane was between 18.4%and 20.5%.
Analytical Chemistry Letter
dx.doi.org/10.1021/ac4009594 | Anal. Chem. 2013, 85, 5622−56265624
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as well as the collection of adenosine triphosphate (ATP) released from red blood cells 
flowing through the channels while simultaneously measuring oxygen concentration (release 
stimulus). For collection of ATP, polyester membrane inserts were fitted into a couple of well 
ports integrated in the device. Collected ATP was then analysed by chemiluminescence 
detection. 
 
 
FIG. 4. Microfluidic chip for electrochemical detection: a–b) schematics of the chip showing the 
threaded ports; c) picture showing alignment of both working and pseudo-reference electrodes with 
the channel; d) picture showing the chip connected to the syringe pump. Reprinted with permission 
from Erkal et al., Lab Chip 14(12), 2023 (2014). Copyright 2014 Royal Society of Chemistry 
 
A microfluidic chip integrating ports for a three-electrode system was recently produced from 
PLA by FDM, and was used for specific electrochemical detection of influenza virus.
51
 
Influenza hemagglutinin labelled with CdS quantum dots was first isolated within the 
reaction chamber by glycan-modified paramagnetic beads via hemagglutinin-glycan 
interaction. Electrochemical quantification of cadmium(II) ions by differential pulse 
voltammetry was then carried out to determine the presence of the virus.  
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FDM has also been investigated for fabrication of capillary valves in centrifugal microfluidic 
discs.
52
 Results showed that 3D printing can be considered a viable alternative to other 
fabrication techniques typically employed for the fabrication of microfluidic discs (e.g. CNC 
milling and soft lithography) in view of their application in the development of biochemical 
assays.
53
 Although channels produced in ABS possessed ridged or ‘‘scalloped’’ patterns, 
structures containing predictably-operable valves were obtained. Valve structures comprising 
channels with widths of 254 and 508 μm, and heights between 254 and 1016 μm were 
successfully fabricated.  
There are few examples in the literature where direct internal 3D laser writing has been used 
for production of microfluidic platforms for biological applications. This might be due to the 
fact that ultrafast lasers have been quite expensive for most research labs until very recently. 
In addition these systems require highly skilled personnel operating such lasers. A 1045 nm 
femtosecond laser was used to fabricate a microfluidic platform for investigation of the 
factors that induce cyanobacteria Phormidium to glide toward a seedling root which could be 
used for promoting accelerated growth of vegetables.
54
 Internal microfluidic channels were 
produced in photostructurable glass (Foturan) followed by annealing and successive wet 
etching in dilute hydrofluoric acid solution. Optical waveguides and lenses used for imaging 
of Phormidium were then also created with the femtosecond laser in a single step process. 
Results showed that CO2 secreted from the seedling root was the most likely cause for the 
Phormidium gliding (see Figure 5).  A similar fabrication method was previously developed 
by the same group using a 775 nm femtosecond laser.
55
 In this work, the biophotonic 
microchip was used to inspect the movement of living Euglena’s flagellum within the 
channels. This new microchip design allowed for wider field of view and greater depth of 
focus to readily image living microorganisms in a manner which could not be performed by 
conventional optical observation in Petri dishes using high-speed camera capture. 
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FIG. 5. Investigation of the attractant inducing Phormidium gliding within the microfluidic channels. 
Adapted with permission from Hanada et al., Lab Chip 11(12), 2109 (2011). Copyright 2011 Royal 
Society of Chemistry 
 
V. Concluding remarks 
3D printing fabrication methods have to date not been widely utilised within the field of 
microfluidics. This can be attributed to the poor resolution of cheap equipment, the 
prohibitively high cost of high resolution equipment, and the lack of availability of suitable 
materials from 3D printing technologies. However, the expiration of key 3D printing patents 
in recent years has brought many 3D printing technologies to the consumer market, making 
them more affordable and spurring competition between the newly formed companies 
18 
 
supplying into this area. The rapid increase in the capabilities and availability of these rapid 
prototyping technologies, and at much reduced cost, has open the door to the exploration of 
3D printing as an alternative to more conventional 2D microfabrication methods typically 
employed in the fabrication of microfluidics platforms. Recent studies have actually shown 
that 3D printing methods can effectively be used for producing micrometer scale internal 
channels within bulk biocompatible and transparent materials for a cost as low as $2 per 
chip,
44
 confirming the feasibility of this approach for rapid prototyping of cost-effective 
microfluidic devices in a single step. Continuous improvements in resolution are expected, 
even below the currently available TPP devices. However, it is clear that further research is 
needed in two main areas: removal of support material from complex geometries and 
development of new resins for SL.  
 
Direct internal 3D laser writing of microchannels presents another promising option for fast 
accurate production of complicated 3D microfluidic systems. Using a high frequency pulsed 
femtosecond laser it is possible to create internal channels in a range of glass and polymer 
materials. Internal optics and actuating elements can also be fabricated using such laser 
writing techniques. However, the equipment complexity and operator’s skill level is still 
relatively high for this fabrication route in comparison to 3D printing methods.  
 
The benefit of these direct 3D fabrication technologies can be seen in the biological 
applications for which they have already been used. Resin biocompatibility and optical 
transparency as well as high accuracy of SL 3D printing have allowed fabrication of 
microfluidics platforms for applications in cell culture and cell imaging. New microfluidic 
designs integrating electrodes and membrane inserts were successfully employed in the 
19 
 
electrochemical detection of neurotransmitters and viruses, collection of biologically relevant 
analytes (e.g. ATP), and drug transport studies. Direct internal 3D laser writing also 
facilitated the production of suitable microfluidic-based photonic platforms for observation of 
living organisms. Based on all the above, it is fair to expect that direct 3D fabrication 
methods will play an important role in biomicrofluidics in the near future, with possible new 
applications in POC diagnostics, cell culture, drug discovery, organs-on-chip, or even 
forensic analysis, to name just a few. 
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